These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34012663)

  • 1. The use of neoadjuvant lobar radioembolization prior to major hepatic resection for malignancy results in a low rate of post hepatectomy liver failure.
    Ahmed A; Stauffer JA; LeGout JD; Burns J; Croome K; Paz-Fumagalli R; Frey G; Toskich B
    J Gastrointest Oncol; 2021 Apr; 12(2):751-761. PubMed ID: 34012663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma.
    Gabr A; Abouchaleh N; Ali R; Baker T; Caicedo J; Katariya N; Abecassis M; Riaz A; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2018 Nov; 29(11):1502-1510.e1. PubMed ID: 30268638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (90) Y radiation lobectomy: Outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes.
    Lewandowski RJ; Donahue L; Chokechanachaisakul A; Kulik L; Mouli S; Caicedo J; Abecassis M; Fryer J; Salem R; Baker T
    J Surg Oncol; 2016 Jul; 114(1):99-105. PubMed ID: 27103352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Yttrium-90 Transarterial Radioembolization with Resin Microspheres Prescribed Using the Medical Internal Radiation Dose Model for Intrahepatic Cholangiocarcinoma.
    Sarwar A; Ali A; Ljuboja D; Weinstein JL; Shenoy-Bhangle AS; Nasser IA; Morrow MK; Faintuch S; Curry MP; Bullock AJ; Ahmed M
    J Vasc Interv Radiol; 2021 Nov; 32(11):1560-1568. PubMed ID: 34454031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and safety of liver transplantation or resection after transarterial radioembolization with Yttrium-90 for unresectable hepatocellular carcinoma.
    Labgaa I; Tabrizian P; Titano J; Kim E; Thung SN; Florman S; Schwartz M; Melloul E
    HPB (Oxford); 2019 Nov; 21(11):1497-1504. PubMed ID: 31005494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety of hepatectomy after transarterial radioembolization: Single institution experience and review of the literature.
    Noda C; Williams GA; Foltz G; Kim H; Sanford DE; Hammill CW; Fields RC
    J Surg Oncol; 2020 Nov; 122(6):1114-1121. PubMed ID: 32662066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transarterial Radioembolization to Impact Liver Volumetry: When and How.
    Najafi A; Binkert CA
    Cardiovasc Intervent Radiol; 2022 Nov; 45(11):1646-1650. PubMed ID: 35859212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection.
    Vouche M; Lewandowski RJ; Atassi R; Memon K; Gates VL; Ryu RK; Gaba RC; Mulcahy MF; Baker T; Sato K; Hickey R; Ganger D; Riaz A; Fryer J; Caicedo JC; Abecassis M; Kulik L; Salem R
    J Hepatol; 2013 Nov; 59(5):1029-36. PubMed ID: 23811303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial radioembolization with yttrium-90 of unresectable primary hepatic malignancy in children.
    Aguado A; Ristagno R; Towbin AJ; Gupta A; Haberle S; Qi Z; Patel MN; Kukreja KU; Tiao GM; Geller JI
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27510. PubMed ID: 30406959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Trans-Arterial Yttrium-90 Radioembolization in Patients with Unresectable Liver-Dominant Metastatic or Primary Hepatic Soft Tissue Sarcomas.
    Testa S; Bui NQ; Wang DS; Louie JD; Sze DY; Ganjoo KN
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of prior hepatectomy on the safety and efficacy of radioembolization with yttrium-90 microspheres for patients with unresectable liver tumors.
    Bester L; Feitelson S; Milner B; Chua TC; Morris DL
    Am J Clin Oncol; 2014 Oct; 37(5):454-60. PubMed ID: 23388564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bridging and downstaging role of trans-arterial radio-embolization for expected small remnant volume before liver resection for hepatocellular carcinoma.
    Shehta A; Lee JM; Suh KS; Kim HC; Hong SK; Cho JH; Yi NJ; Lee KW
    Ann Hepatobiliary Pancreat Surg; 2020 Nov; 24(4):421-430. PubMed ID: 33234744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablative-Transarterial Radioembolization resulting in complete histopathological response of hepatocellular carcinoma in the resected liver specimen after salvage hepatectomy.
    Chung TK; Leung TW; Chung CH; Leung HH; Lau WY
    Int J Surg Case Rep; 2022 Jan; 90():106679. PubMed ID: 34972009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Y-90 Radioembolization After Prior Major Hepatic Resection.
    Zimmermann M; Schulze-Hagen M; Liebl M; Pedersoli F; Goerg F; Ulmer TF; Heinzel A; Isfort P; Kuhl C; Bruners P
    Cardiovasc Intervent Radiol; 2017 Aug; 40(8):1206-1212. PubMed ID: 28357572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis.
    Egger ME; Armstrong E; Martin RC; Scoggins CR; Philips P; Shah M; Konda B; Dillhoff M; Pawlik TM; Cloyd JM
    J Am Coll Surg; 2020 Apr; 230(4):363-370. PubMed ID: 32032719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib.
    Teyateeti A; Mahvash A; Long J; Abdelsalam M; Avritscher R; Kaseb A; Odisio B; Ravizzini G; Surasi D; Teyateeti A; Macapinlac H; Kappadath SC
    World J Gastroenterol; 2021 Dec; 27(47):8166-8181. PubMed ID: 35068861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
    Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival analysis of transarterial radioembolization with yttrium-90 for hepatocellular carcinoma patients with HBV infection.
    She WH; Cheung TT; Yau TC; Chan AC; Chok KS; Chu FS; Liu RK; Poon RT; Chan SC; Fan ST; Lo CM
    Hepatobiliary Surg Nutr; 2014 Aug; 3(4):185-93. PubMed ID: 25202695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated radioembolization in advanced liver cancer.
    Masthoff M; Schindler P; Harders F; Heindel W; Wilms C; Schmidt HH; Pascher A; Stegger L; Rahbar K; Wildgruber M; Köhler M
    Ann Transl Med; 2020 Sep; 8(17):1055. PubMed ID: 33145274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver Resection After Selective Internal Radiation Therapy with Yttrium-90: Safety and Outcomes.
    Mafeld S; Littler P; Hayhurst H; Manas D; Jackson R; Moir J; French J
    J Gastrointest Cancer; 2020 Mar; 51(1):152-158. PubMed ID: 30911980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.